Effect of probenecid on the elimination and protein binding of ceftriaxone
- PMID: 3383987
- DOI: 10.1007/BF00614552
Effect of probenecid on the elimination and protein binding of ceftriaxone
Abstract
The kinetics and binding parameters of ceftriaxone have been characterized in eight normal subjects who received, in sequence, 1.0 g ceftriaxone and 1.0 g ceftriaxone together with 250 and 500 mg probenecid q.i.d. Probenecid increased the total systemic clearance (CLTS) from 0.244 to 0.312 ml/min/kg, whereas the terminal half-life (t1/2T (beta)) fell from 8.1 to 6.5 h. In contrast, the renal clearance of free ceftriaxone (CLFR) was decreased from 2.09 to 1.67 ml/min/kg, confirming a small but significant contribution of tubular secretion to the renal elimination of ceftriaxone. The final value of CLFR was attained with the lower dose probenecid, whereas the non-renal clearance of free ceftriaxone (CLFNR) fell progressively from 2.78 to 1.90 ml/min/kg with the increasing probenecid dose. The total decrease in the systemic clearance of free ceftriaxone (CLFS) after the higher dose of probenecid was about 30% (4.87 to 3.57 ml/min/kg). As a consequence of a decreased affinity constant (KA), the average free fraction in plasma (f) was increased by 54% after the low dose and by 74% after the high dose of probenecid. The protein binding interaction between probenecid and ceftriaxone appears to be unique. The results are of limited clinical consequence for ceftriaxone but they emphasise the importance of evaluating the kinetics of the free drug when examining interactions involving probenecid.
Similar articles
-
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.Clin Pharmacol Ther. 1981 May;29(5):650-7. doi: 10.1038/clpt.1981.90. Clin Pharmacol Ther. 1981. PMID: 7053242
-
Lack of probenecid effect on nonrenal excretion of ceftriaxone in anephric patients.J Clin Pharmacol. 1990 May;30(5):449-53. doi: 10.1002/j.1552-4604.1990.tb03484.x. J Clin Pharmacol. 1990. PMID: 2347956 Clinical Trial.
-
Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.Biopharm Drug Dispos. 1989 Mar-Apr;10(2):137-52. doi: 10.1002/bdd.2510100204. Biopharm Drug Dispos. 1989. PMID: 2706315
-
Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam.Biochem Pharmacol. 1990 Sep 15;40(6):1247-53. doi: 10.1016/0006-2952(90)90390-7. Biochem Pharmacol. 1990. PMID: 2403378
-
Pharmacokinetics of ceftriaxone.Hosp Pract (Off Ed). 1991 Sep;26 Suppl 5:7-13; discussion 52-4. doi: 10.1080/21548331.1991.11707737. Hosp Pract (Off Ed). 1991. PMID: 1918224 Review.
Cited by
-
No effect of probenecid on the renal and biliary clearances of digoxin in man.Br J Clin Pharmacol. 1991 Jul;32(1):63-7. doi: 10.1111/j.1365-2125.1991.tb05614.x. Br J Clin Pharmacol. 1991. PMID: 1888643 Free PMC article.
-
Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Pharm Res. 2015 Aug;32(8):2477-502. doi: 10.1007/s11095-015-1711-5. Epub 2015 May 14. Pharm Res. 2015. PMID: 25972096 Review.
-
Ceftriaxone disposition in open-heart surgery patients.Antimicrob Agents Chemother. 1989 Jun;33(6):850-6. doi: 10.1128/AAC.33.6.850. Antimicrob Agents Chemother. 1989. PMID: 2764536 Free PMC article.
-
Cephalosporin-probenecid drug interactions.Clin Pharmacokinet. 1993 Apr;24(4):289-300. doi: 10.2165/00003088-199324040-00003. Clin Pharmacokinet. 1993. PMID: 8491057 Review.
-
Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats.Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):505-517. doi: 10.1007/s13318-018-0530-6. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30511237
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials